Notification of Transaction by Person Discharging Managerial Responsibilities (“PDMR”)
29 JUNE 2018
NORTHERN VENTURE TRUST PLC
NOTIFICATION OF TRANSACTION BY PERSON DISCHARGING MANAGERIAL RESPONSIBILITIES (“PDMR”)
Northern Venture Trust PLC (“the Company”) has been notified that in respect of the interim dividend for the financial year ended 30 September 2018 paid on 29 June 2018, the following PDMR acquired ordinary shares of 25 pence each in the Company through his participation in the Company's dividend investment scheme.
| PDMR | Date acquired | No. of shares acquired | Purchase price per share (£) | Total current shareholding | |
| Nigel Jonathan Beer | 29 June 2018 | 5,850 | £ | 0.687 | 206,784 |
The Notification of Dealing Form for the above PDMR can be found below.
This notification is made in accordance with the Market Abuse Regulation.
Enquiries:
Simon John/James Bryce, NVM Private Equity LLP - 0191 244 6000
Website: www.nvm.co.uk
Neither the contents of the NVM Private Equity LLP website nor the contents of any website accessible from hyperlinks on the NVM Private Equity LLP website (or any other website) is incorporated into, or forms part of, this announcement.
NOTIFICATION OF DEALING FORM
1 Details of the person discharging managerial responsibilities / person closely associated
| a) | Name | Nigel Jonathan Beer |
2 Reason for the notification
| a) | Position/status | Director |
| b) | Initial notification/ Amendment | Initial Notification |
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| a) | Name | Northern Venture Trust PLC |
| b) | LEI | 213800HR3R4WFICYFN46 |
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary Shares of 25p each GB0006450703 |
| b) | Nature of the transaction | Issue of Ordinary Shares under the Company's dividend investment scheme |
| c) | Price(s) and volume(s) | Price(s) £0.687 Volume(s) 5,850 |
| d) | Aggregated information - Aggregated volume - Price | Aggregate price £0.687 Aggregate volume 5,850 Aggregate total £4,018.95 |
| e) | Date of the transaction | 29 JUNE 2018 |
| f) | Place of the transaction | XLON |
© 2018 GlobeNewswire, Inc. All Rights Reserved.
Regeneron Pharmaceuticals' (Nasdaq: REGN) REGEN-COV2 is First Antibody Cocktail for COVID-19 to Receive FDA Emergency Use Authorization
